Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for ...

The US Food and Drug Administration (FDA) has issued several warning letters to pharmaceutical manufacturers in India and ...

President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

which included “multiple microbiological contamination events,” the FDA noted. The French pharma also failed to show that its production process can reproducibly manufacture an API to certain ...

Aurobindo Pharma's shares drop over 3% after FDA inspection results in VAI classification for subsidiary's API plant.

Bajaj Health has also extended the offer for Pimavanserin to several leading pharma companies to ensure availability in ...

Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.